Insmed Inc. (INSM)
Market Closed
22 Jul, 20:00
$
106. 64
-1.98
-1.8229%
After Hours
$
+1.36 +1.2753% 108. 00
23.48B Market Cap
- P/E Ratio
- Div Yield
1.73M Volume
-5.21 Eps
$ 108.62
Previous Close 
Want to track INSM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Insmed's lung disease drug succeeds in late-stage study
Insmed said its experimental drug to treat a type of chronic lung disease helped significantly reduce respiratory symptoms such as chronic cough in a late-stage study, prompting its shares to double in premarket trading on Tuesday.
Reuters | 2 years ago
